Our country faces a serious and complex public health crisis related to opioid addiction and abuse. It’s an epidemic that affects all of us, professionally and personally.
As a pharmaceutical wholesale distributor, Cardinal Health has a responsibility, along with everyone in the prescription drug supply chain, to help solve this national challenge.
Our commitment to helping solve this problem is unwavering, and includes the following:
- Anti-Diversion: We lead our industry in anti-diversion strategies to help prevent opioids from being diverted for misuse or abuse. We maintain a sophisticated, state-of-the-art program to identify, block and report to regulators those orders of prescription controlled medications that do not meet our strict criteria. Our system includes advanced analytics, technology and on-the-ground deployment of investigators to evaluate all pharmacies and scrutinize all controlled substance orders. In fulfilling our responsibility, we also rely on the expertise and experience of professionals like Linden Barber, a war veteran and law enforcement professional whose knowledge and integrity has been invaluable to Cardinal Health’s anti-diversion efforts.
- Prevention Education: For over a decade, we’ve funded prevention education programs to ensure school-age kids, patients, pharmacists and prescribers know about the dangers of misuse and abuse of opioids. The Cardinal Health Foundation, in partnership with The Ohio State University College of Pharmacy, developed Generation Rx, a national prescription drug education and awareness program for people of all ages – from teens to student pharmacists to community leaders – about the dangers of misusing prescription medications.
- Drug Take Back & Disposal: Our employees have collectively volunteered thousands of hours to community service to support drug take-back days and community awareness and education efforts at schools, senior centers and elsewhere.
We’ve prioritized these activities and responses for a simple reason: it’s the right thing to do. Our people care deeply about this issue and the devastation it has caused American families and communities. We will continue to work alongside regulators, manufacturers, prescribers, pharmacists, educators, patients and others to fight opioid abuse and addiction.
For additional information about the facts around our industry’s role, please visit Healthcare Distribution Alliance’s website: https://www.hda.org/news/2017-10-15-correcting-the-record.
For further information: Ellen Barry, firstname.lastname@example.org, 614.553.3858